Close

Goldman Sachs Upgrades Mead Johnson Nutrition (MJN) to Buy; Strong Fundamentals and M&A Target

July 15, 2014 6:46 AM EDT Send to a Friend
Goldman Sachs upgraded Mead Johnson Nutrition (NYSE: MJN) from Neutral to Buy with a price target of $107.00 (from $91.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login